Cigna Investments Inc. New has trimmed its position in Accenture PLC by 2.7%, selling 170 shares in the second quarter. The move leaves the firm with 6,136 shares valued at $1.83 million, as reported in a recent SEC filing.
Cigna Investments Inc. New Has $1.83 Million Stock Position in Accenture PLC $ACN

Key Takeaways:
- Cigna Investments Inc. New holds a $1.83 million stake in Accenture.
- Its stake dropped by 2.7% during the second quarter.
- The fund sold 170 shares in Accenture.
- The total number of shares currently stands at 6,136.
- The disclosure was made in the company’s most recent SEC filing.
Background
Cigna Investments Inc. New recently released its quarterly disclosure to the Securities & Exchange Commission, shedding light on the firm’s investment strategies in the information technology services sector. Accenture PLC, listed on the NYSE under the ticker symbol ACN, was among the notable companies included in the filing.
Second Quarter Stock Adjustment
The fund reported a 2.7% reduction in its Accenture stake during the second quarter. This move was evidenced by a sale of 170 shares, reflecting a measured approach while still maintaining a substantial position.
Current Holdings Value
According to the same filing, Cigna Investments Inc. New’s stake is now valued at $1.83 million. With 6,136 shares of the information technology services provider in its portfolio, the fund continues to demonstrate confidence in the stock while slightly scaling back its exposure.
SEC Disclosure
All of these details stem from the firm’s most recent submission to the Securities & Exchange Commission, a regular requirement designed to provide transparency in financial markets. By adhering to these filing standards, Cigna gives investors and the public insight into its investment movements.
Looking Ahead
While the disclosure emphasizes the sale of 170 shares, the fund’s overall investment in Accenture remains significant. Both current and prospective Accenture shareholders may watch future filings for additional clues about Cigna’s long-term strategy, though no further updates have been provided at this time.